We are live on ! Find out more
TPCW

TD Private Client Wealth Portfolio holdings

AUM $4.82B
1-Year Est. Return 15.21%
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
+15.21%
3 Year Est. Return
+48.23%
5 Year Est. Return
+55.79%
10 Year Est. Return
AUM
$3.05B
AUM Growth
+$281M
Cap. Flow
+$95.5M
Cap. Flow %
3.13%
Top 10 Hldgs %
32.37%
Holding
1,279
New
62
Increased
530
Reduced
502
Closed
64

Sector Composition

Rank Sector Weight
1 Technology 8.19%
2 Financials 5.38%
3 Healthcare 4.84%
4 Industrials 3.65%
5 Consumer Discretionary 2.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMP icon
126
Ameriprise Financial
AMP
$47.2B
$4.02M 0.13%
9,162
-191
-2% -$76.5K
VWO icon
127
Vanguard FTSE Emerging Markets ETF
VWO
$119B
$3.95M 0.13%
94,568
-21,188
-18% -$865K
VRSK icon
128
Verisk Analytics
VRSK
$26.4B
$3.92M 0.13%
16,628
-6,820
-29% -$1.64M
BLK icon
129
Blackrock
BLK
$163B
$3.9M 0.13%
4,682
+73
+2% +$58.6K
GILD icon
130
Gilead Sciences
GILD
$166B
$3.88M 0.13%
52,921
+13,515
+34% +$1.04M
IUSG icon
131
iShares Core S&P US Growth ETF
IUSG
$31.5B
$3.85M 0.13%
32,842
+4,570
+16% +$508K
AXP icon
132
American Express
AXP
$240B
$3.76M 0.12%
16,522
+2,975
+22% +$617K
T icon
133
AT&T
T
$152B
$3.76M 0.12%
213,712
+1,137
+0.5% +$19.4K
LPLA icon
134
LPL Financial
LPLA
$26.2B
$3.75M 0.12%
14,177
+994
+8% +$251K
IJT icon
135
iShares S&P Small-Cap 600 Growth ETF
IJT
$8.25B
$3.74M 0.12%
28,643
-403
-1% -$50.3K
ADI icon
136
Analog Devices
ADI
$182B
$3.73M 0.12%
18,879
-5,369
-22% -$1.03M
TMO icon
137
Thermo Fisher Scientific
TMO
$196B
$3.71M 0.12%
6,391
+369
+6% +$207K
LYB icon
138
LyondellBasell Industries
LYB
$19.5B
$3.7M 0.12%
36,213
-5,982
-14% -$582K
ABT icon
139
Abbott
ABT
$177B
$3.69M 0.12%
32,507
+1,808
+6% +$207K
XOM icon
140
ExxonMobil
XOM
$616B
$3.67M 0.12%
31,592
+2,259
+8% +$236K
XLK icon
141
State Street Technology Select Sector SPDR ETF
XLK
$115B
$3.6M 0.12%
34,606
+4,498
+15% +$455K
IWR icon
142
iShares Russell Mid-Cap ETF
IWR
$56.5B
$3.6M 0.12%
42,855
-4,173
-9% -$331K
BSX icon
143
Boston Scientific
BSX
$65.5B
$3.58M 0.12%
52,343
-27,018
-34% -$1.74M
VEU icon
144
Vanguard FTSE All-World ex-US ETF
VEU
$65.3B
$3.5M 0.11%
59,644
-7,734
-11% -$437K
ENB icon
145
Enbridge
ENB
$122B
$3.48M 0.11%
96,297
-12,807
-12% -$454K
BMY icon
146
Bristol-Myers Squibb
BMY
$123B
$3.47M 0.11%
64,017
+35,725
+126% +$1.82M
KKR icon
147
KKR & Co
KKR
$86.8B
$3.38M 0.11%
33,622
+33,130
+6,734% +$3.05M
MU icon
148
Micron Technology
MU
$974B
$3.38M 0.11%
28,660
+843
+3% +$76.3K
CRL icon
149
Charles River Laboratories
CRL
$10.5B
$3.32M 0.11%
12,249
+2,612
+27% +$624K
CRM icon
150
Salesforce
CRM
$142B
$3.3M 0.11%
10,945
+2,955
+37% +$853K

Similar funds

TD Private Client Wealth's Q1 2024 Portfolio in Review

As of Q1 2024, TD Private Client Wealth held 1,279 positions worth $3.05B, up 10% from $2.77B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

TD Private Client Wealth deployed $95.5M of net new capital in Q1 2024, opening 62 new positions and adding to 530 existing holdings. Its largest new stake was Cooper Companies: 27,603 shares worth $2.8M.

By sector, the portfolio is most concentrated in Technology at 8.2% of assets, down from 8.3% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Russell 1000 Value ETF, an estimated $5.02M trimmed.

  • TD Private Client Wealth's largest Q1 2024 buy was Cooper Companies: 27,603 shares worth $2.8M.
  • TD Private Client Wealth added most to State Street SPDR Portfolio S&P 500 ETF in Q1 2024, an estimated $14.8M increase.
  • TD Private Client Wealth's biggest Q1 2024 reduction was iShares Russell 1000 Value ETF, cutting an estimated $5.02M.
  • TD Private Client Wealth fully exited Littelfuse in Q1 2024, selling an estimated $498K.
  • TD Private Client Wealth's ten largest holdings make up 32% of its $3.05B portfolio in Q1 2024.
  • TD Private Client Wealth opened 62 new positions and closed 64 in Q1 2024.
  • TD Private Client Wealth's portfolio value rose 10% quarter-over-quarter to $3.05B.

Based on TD Private Client Wealth's 13F filing for Q1 2024, filed 16 Aug 2024.